Casper Marc N's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Nov 18, 2022
- Accession no.
- 0001127602-22-026032
- Filed
- Nov 18, 2022
- Trade date
- Nov 16-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 27 non-derivative transactions. Open-market sales total $7.97M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casper Marc NCIK 0001216055 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | Common Stock | SSaleDisposed | −600 | $532.03F2 | −$319,218 | 88,555 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −600 | $532.91F3 | −$319,746 | 87,955 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −812 | $533.97F4 | −$433,583.64 | 87,143 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −2,203 | $535.12F5 | −$1,178,869.36 | 84,940 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −1,318 | $536.10F6 | −$706,579.8 | 83,622 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −100 | $536.83 | −$53,683 | 83,522 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −100 | $537.73 | −$53,773 | 83,422 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −100 | $538.40 | −$53,840 | 83,322 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −100 | $539.47 | −$53,947 | 83,222 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −200 | $540.00 | −$108,000 | 83,022 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −302 | $541.89F7 | −$163,650.78 | 82,720 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −400 | $542.79F8 | −$217,116 | 82,320 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −100 | $543.62 | −$54,362 | 82,220 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −400 | $546.15F9 | −$218,460 | 81,820 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −65 | $547.55 | −$35,590.75 | 81,755 | Indirect | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −100 | $547.79 | −$54,779 | 81,655 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −100 | $519.51 | −$51,951 | 81,555 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −400 | $521.23F10 | −$208,492 | 81,155 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −300 | $522.24F11 | −$156,672 | 80,855 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −660 | $523.66F12 | −$345,615.6 | 80,195 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −900 | $524.60F13 | −$472,140 | 79,295 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −1,000 | $525.60F14 | −$525,600 | 78,295 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −1,809 | $527.09F15 | −$953,505.81 | 76,486 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −850 | $527.93F16 | −$448,740.5 | 75,636 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −876 | $528.94F17 | −$463,351.44 | 74,760 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −505 | $529.87F18 | −$267,584.35 | 74,255 | Indirect | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −100 | $530.70 | −$53,070 | 74,155 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.53 to $532.52, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), and (18) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.58 to $533.26, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.58 to $534.53, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.62 to $535.54, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.76 to $536.57, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.33 to $542.04, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.51 to $543.33, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.06 to $546.23, inclusive.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.83 to $521.65, inclusive.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.86 to $522.85, inclusive.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.20 to $524.11, inclusive.
Referenced by the price of 1 transaction in Table I.
- F13
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.23 to $525.22, inclusive.
Referenced by the price of 1 transaction in Table I.
- F14
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.28 to $526.17, inclusive.
Referenced by the price of 1 transaction in Table I.
- F15
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.50 to $527.49, inclusive.
Referenced by the price of 1 transaction in Table I.
- F16
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.52 to $528.30, inclusive.
Referenced by the price of 1 transaction in Table I.
- F17
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.56 to $529.36, inclusive.
Referenced by the price of 1 transaction in Table I.
- F18
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.63 to $530.32, inclusive.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit List: Exhibit 24 - Confirming Statement